BridgeMD
New treatment option for Diaper Dermatitis
Official title Probiotics for Diaper Dermatitis
ClinicalTrials.gov ID: NCT06755307
What this study is testing
- What it's testing
- The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 2
You may be able to join if
- presence of diaper dermatitis
- age less than two years
You likely can't join if
- previous use of probiotics
- age more than two years
- an acute bacterial infection
- chronic disease
- local use of antibiotics in the anogenital region
The study team makes the final eligibility decision.
Where it's taking place
- Maribor, Slovenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 2 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maribor, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.